Studies have indicated that biochanin A promotes apoptosis by inhibiting the Akt and MAPK pathways, reducing NF-κB activity, and modulating the Bcl-2/Bax ratio [43], demonstrating anti-cancer effects in breast and prostate cancers [44]. This evidence concerns the gene BCL2 and cancer.